chr5-9629794-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_019599.3(TAS2R1):c.239C>T(p.Ala80Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000812 in 1,613,688 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_019599.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAS2R1 | ENST00000382492.4 | c.239C>T | p.Ala80Val | missense_variant | 1/1 | 6 | NM_019599.3 | ENSP00000371932.2 | ||
TAS2R1 | ENST00000514078.1 | c.119C>T | p.Ala40Val | missense_variant | 2/2 | 3 | ENSP00000476190.1 | |||
TAS2R1 | ENST00000506620.1 | c.119C>T | p.Ala40Val | missense_variant | 3/3 | 2 | ENSP00000475387.1 | |||
ENSG00000248525 | ENST00000504182.2 | n.36-6192C>T | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152132Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000881 AC: 22AN: 249720Hom.: 0 AF XY: 0.0000814 AC XY: 11AN XY: 135156
GnomAD4 exome AF: 0.0000828 AC: 121AN: 1461556Hom.: 0 Cov.: 32 AF XY: 0.0000646 AC XY: 47AN XY: 727066
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152132Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74318
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 12, 2024 | The c.239C>T (p.A80V) alteration is located in exon 1 (coding exon 1) of the TAS2R1 gene. This alteration results from a C to T substitution at nucleotide position 239, causing the alanine (A) at amino acid position 80 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at